Clinical characteristics and outcomes of 100 adult patients with pure red cell aplasia
- 23 April 2022
- journal article
- research article
- Published by Springer Nature in Annals of Hematology
- Vol. 101 (7) , 1493-1498
Abstract
Adult pure red cell aplasia (PRCA) is a rare syndrome characterized by a severe normocytic anemia, reticulocytopenia, and absence of erythroblasts from bone marrow. The standard treatment has not yet been established for PRCA, although cyclosporine (CsA), corticosteroids (CS) showed a response in PRCA. We retrospectively analyzed the clinical data of 60 primary and 40 secondary adult patients with acquired PRCA. The proportion of secondary PRCA is relatively high and commonly associated with large granular lymphocyte leukemia (LGLL) (28 cases, 70.0%). The remission-induced regimens included CS, CsA, or other agents, and the response rate was 66.7%, 71.4%, and 50%, respectively (P = 0.336). When treating with CsA, the response rate of LGLL-associated PRCA was lower than primary PRCA (42.1% vs 85.7%, P = 0.001). Logistic regression analysis showed that ORR was inversely related to LGLL-associated PRCA. LGLL-associated PRCA had poor therapeutic efficacy to CsA.Keywords
Funding Information
- State Administration of Traditional Chinese Medicine Industry Specialty (201407001-4)
- National Public Health Grand Research Foundation (201202017)
- Priority Academic Program Development of Jiangsu Higher Education Institute (JX10231801)
- Jiangsu Provincial Special Program of Medical Science (BL201408)
This publication has 25 references indexed in Scilit:
- A case of pure red cell aplasia and immune thrombocytopenia complicating systemic lupus erythematosus: Responseto rituximab and cyclophosphamideLupus, 2011
- Rituximab–cyclophosphamide–dexamethasone combination in the management of autoimmune cytopenias associated with chronic lymphocytic leukemiaLeukemia, 2010
- Long-term follow-up of patients with moderate aplastic anemia and pure red cell aplasia treated with daclizumabHaematologica, 2010
- Alemtuzumab is safe and effective as immunosuppressive treatment for aplastic anaemia and single‐lineage marrow failure: a pilot study and a survey from the EBMT WPSAABritish Journal of Haematology, 2010
- Clinical analysis of 52 patients with granular lymphocyte proliferative disorder (GLPD) showed frequent anemia in indolent T‐cell GLPD in JapanEuropean Journal of Haematology, 2009
- Long-term responses and outcomes following immunosuppressive therapy in large granular lymphocyte leukemia-associated pure red cell aplasia: a Nationwide Cohort Study in Japan for the PRCA Collaborative Study GroupHaematologica, 2008
- Long-term response and outcome following immunosuppressive therapy in thymoma-associated pure red cell aplasia: a nationwide cohort study in Japan by the PRCA collaborative study groupHaematologica, 2008
- Long-term outcome of patients with acquired primary idiopathic pure red cell aplasia receiving cyclosporine A. A nationwide cohort study in Japan for the PRCA Collaborative Study GroupHaematologica, 2007
- Pure red cell aplasia associated with thymoma: clinical insights from a 50‐year single‐institution experience*British Journal of Haematology, 2006
- Pathogenesis of neutropenia in large granular lymphocyte leukemia and Felty syndromeBlood Reviews, 2006